The role of inflammation in diabetic retinopathy
JV Forrester, L Kuffova, M Delibegovic - Frontiers in immunology, 2020 - frontiersin.org
Inflammation is central to pathogenic processes in diabetes mellitus and the metabolic
syndrome and particularly implicates innate immunity in the development of complications …
syndrome and particularly implicates innate immunity in the development of complications …
Strategies to tackle the global burden of diabetic retinopathy: from epidemiology to artificial intelligence
TY Wong, C Sabanayagam - Ophthalmologica, 2020 - karger.com
Diabetes is a global public health disease projected to affect 642 million adults by 2040, with
about 75% residing in low-and middle-income countries. Diabetic retinopathy (DR) affects 1 …
about 75% residing in low-and middle-income countries. Diabetic retinopathy (DR) affects 1 …
Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017
M Kinoshita, K Yokote, H Arai, M Iida… - … of atherosclerosis and …, 2018 - jstage.jst.go.jp
Every 5 years, the JAS publishes guidelines for the treatment of dyslipidemia and
atherosclerosis. To date, this society has released four such guidelines. Since 2007, the JAS …
atherosclerosis. To date, this society has released four such guidelines. Since 2007, the JAS …
Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study
JA Critchley, IM Carey, T Harris, S DeWilde… - Diabetes …, 2018 - Am Diabetes Assoc
OBJECTIVE Diabetes mellitus (DM) increases the risk of infections, but the effect of better
control has not been thoroughly investigated. RESEARCH DESIGN AND METHODS With …
control has not been thoroughly investigated. RESEARCH DESIGN AND METHODS With …
Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes
SJ Griffin, JK Leaver, GJ Irving - Diabetologia, 2017 - Springer
Aims/hypothesis Metformin is the most-prescribed oral medication to lower blood glucose
worldwide. Yet previous systematic reviews have raised doubts about its effectiveness in …
worldwide. Yet previous systematic reviews have raised doubts about its effectiveness in …
Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised …
S Zoungas, H Arima, HC Gerstein… - The lancet Diabetes & …, 2017 - thelancet.com
Background Intensive glucose control is understood to prevent complications in adults with
type 2 diabetes. We aimed to more precisely estimate the effects of more intensive glucose …
type 2 diabetes. We aimed to more precisely estimate the effects of more intensive glucose …
[PDF][PDF] 2013 ESH/ESC Guidelines for the management of arterial hypertension
G Mancia, R Fagard, K Narkiewicz… - Arterial …, 2013 - journals.viamedica.pl
Wytyczne dotyczące nadciśnienia tętniczego opublikowane w 2013 r. przez Europejskie
Towarzystwo Nadciśnienia Tętniczego (ESH) i Europejskie Towarzystwo Kardiologiczne …
Towarzystwo Nadciśnienia Tętniczego (ESH) i Europejskie Towarzystwo Kardiologiczne …
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Glucose metabolism is normally regulated by a feedback loop including islet β cells and
insulin-sensitive tissues, in which tissue sensitivity to insulin affects magnitude of β-cell …
insulin-sensitive tissues, in which tissue sensitivity to insulin affects magnitude of β-cell …
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and …
Authors/Task Force Members, L Rydén… - European heart …, 2013 - academic.oup.com
ESC Guidelines 3039 administrative staff and by the referees and supervisory committees of
the two organizations. It is our hope that this huge effort has generated guidelines that will …
the two organizations. It is our hope that this huge effort has generated guidelines that will …
Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial
K Ueki, T Sasako, Y Okazaki, M Kato… - The lancet Diabetes & …, 2017 - thelancet.com
Background Limited evidence suggests that multifactorial interventions for control of
glucose, blood pressure, and lipids reduce macrovascular complications and mortality in …
glucose, blood pressure, and lipids reduce macrovascular complications and mortality in …